Evidence map›Paper›PMID 36683098›Full record

ArticleArchives of osteoporosis2023

A real-world study of treatment patterns among patients with osteoporotic fracture: analysis of a Japanese hospital database.

Hiroshi Hagino, Yoko Yoshinaga, Etsuro Hamaya, Tzu-Chieh Lin, Mayank Ajmera, Juliana Meyers

Open access · hybridAbstract read
In one paragraph

Article in Archives of osteoporosis, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Hiroshi HaginoSchool of Health Sciences, Tottori University, Tottori, Japan. hagino@tottori-u.ac.jp.ORCID http://orcid.org/0000-0001-8053-1095
Yoko YoshinagaMedical Affairs, Amgen K.K, Tokyo, Japan.
Etsuro HamayaMedical Affairs, Amgen K.K, Tokyo, Japan.
Tzu-Chieh LinCenter for Observational Research, Amgen, Inc, Thousand Oaks, USA.
Mayank AjmeraDepartment of Health Economics and Outcomes Strategy, RTI Health Solutions, Research Triangle Park, NC, USA.
Juliana MeyersDepartment of Health Economics and Outcomes Strategy, RTI Health Solutions, Research Triangle Park, NC, USA.
RTI Health Solutions · USAmgen (United States) · USTottori University of Environmental Studies · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Health records of patients hospitalized for osteoporotic fracture were analyzed. Prior to the index hospital admission, most patients were not receiving any antiosteoporotic treatment. During the index hospitalization visit, 25.5% of patients received antiosteoporotic treatment. The most common treatment regimens were active vitamin D PURPOSE: To examine the real-world treatment patterns and factors associated with receipt of treatment among Japanese patients with osteoporotic fracture.

methodsWe retrospectively analyzed health records of patients who were hospitalized for osteoporotic fracture between February 2016 and February 2018 in Japan. The type and duration of treatment with antiosteoporotic medications prescribed during hospital stays and after discharge were examined using descriptive statistics. Demographic and clinical factors (e.g., age, previous diagnoses, Charlson Comorbidity Index scores) associated with osteoporotic treatment were explored using multivariable logistic regression.

resultsA total of 112,275 patient medical records were evaluated, including 56,574 records from patients with hip fracture, 26,681 records from patients with vertebrae fracture, and 29,020 patients with non-vertebral non-hip fractures. Prior to the index hospital admission, most patients (91.7%, n = 102,919) were not receiving any antiosteoporotic treatment. For those receiving treatment, active vitamin D

conclusionDespite osteoporotic fracture being a major health concern within older Japanese populations, treatment with antiosteoporotic medication regimens remains generally low.

Indexed as

Bone Density Conservation AgentsHip FracturesOsteoporotic FracturesDiphosphonatesEast Asian PeopleHospitalsHumansRetrospective StudiesTeriparatideVitamin DBone Density Conservation AgentsDiphosphonatesTeriparatideVitamin DAntiosteoporotic medicationsOsteoporosisOsteoporosis fractureRetrospective database analysisTreatment adherenceTreatment patterns

Identifiers

PMID36683098
PMCPMC9868038
OpenAlexW4317716361

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.